TY - JOUR
T1 - The impact of prior stroke on the outcome of patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
AU - Didier, Romain
AU - Koifman, Edward
AU - Kiramijyan, Sarkis
AU - Negi, Smita I.
AU - Torguson, Rebecca
AU - Okubagzi, Petros
AU - Pichard, Augusto D.
AU - Waksman, Ron
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Aims The present study aimed to evaluate the impact of prior cardiovascular events (CVE) on outcome in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Methods and results Patients with severe AS undergoing TAVR between May 2007 and March 2015 were included and categorized to patients with and without prior stroke, defined as embolic, hemorrhagic stroke and transit ischemic attack. Baseline, procedural characteristics, in-hospital outcomes, and 1-month and 1-year mortality were compared in accordance with the Valve Academic Research Consortium-2 consensus. A cohort of 662 consecutive patients with severe AS undergoing TAVR were included in the analysis. Of these, 120 patients had prior stroke, and 542 without. Transfemoral access was used in 78% (571), and pre-TAVR balloon aortic valvuloplasty was performed in 87% (574). Patients with prior stroke had a higher mean Society of Thoracic score compared to those without (10.1% versus 8.8%, respectively; p = 0.006) and higher rates of atherosclerotic disease involving the coronary, peripheral, and carotid arteries. Patients with prior stroke also had more occurrence of in-hospital minor stroke (3.3% versus 0.7%; p = 0.04). Nevertheless, similar mortality rates were recorded at 1, 6, and 12 months, and there were no significant differences in major stroke, bleeding, or post-procedure hospital stay between both groups. Conclusion Prior history of stroke infers a higher risk for in-hospital minor stroke, yet no impact on other outcomes post TAVR. Therefore, history of prior stroke should not be considered an exclusion criterion for TAVR in patients with severe AS.
AB - Aims The present study aimed to evaluate the impact of prior cardiovascular events (CVE) on outcome in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Methods and results Patients with severe AS undergoing TAVR between May 2007 and March 2015 were included and categorized to patients with and without prior stroke, defined as embolic, hemorrhagic stroke and transit ischemic attack. Baseline, procedural characteristics, in-hospital outcomes, and 1-month and 1-year mortality were compared in accordance with the Valve Academic Research Consortium-2 consensus. A cohort of 662 consecutive patients with severe AS undergoing TAVR were included in the analysis. Of these, 120 patients had prior stroke, and 542 without. Transfemoral access was used in 78% (571), and pre-TAVR balloon aortic valvuloplasty was performed in 87% (574). Patients with prior stroke had a higher mean Society of Thoracic score compared to those without (10.1% versus 8.8%, respectively; p = 0.006) and higher rates of atherosclerotic disease involving the coronary, peripheral, and carotid arteries. Patients with prior stroke also had more occurrence of in-hospital minor stroke (3.3% versus 0.7%; p = 0.04). Nevertheless, similar mortality rates were recorded at 1, 6, and 12 months, and there were no significant differences in major stroke, bleeding, or post-procedure hospital stay between both groups. Conclusion Prior history of stroke infers a higher risk for in-hospital minor stroke, yet no impact on other outcomes post TAVR. Therefore, history of prior stroke should not be considered an exclusion criterion for TAVR in patients with severe AS.
KW - Severe aortic stenosis
KW - Stroke
KW - Transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=84969592990&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2016.05.003
DO - 10.1016/j.carrev.2016.05.003
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27236630
AN - SCOPUS:84969592990
SN - 1553-8389
VL - 17
SP - 322
EP - 327
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
IS - 5
ER -